The treatment of acute leukaemia
- 1 January 1997
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 349 (9047) , 270-275
- https://doi.org/10.1016/s0140-6736(96)08086-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dose intensification in acute myloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's ATML9 studyBritish Journal of Haematology, 1996
- A randomized study of high-dose cytarabine in induction in acute myeloid leukemia [see comments]Blood, 1996
- Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous LeukemiaNew England Journal of Medicine, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Autonomous Proliferation of Leukemic Cells in Vitro as a Determinant of Prognosis in Adult Acute Myeloid LeukemiaNew England Journal of Medicine, 1993
- Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood)British Journal of Haematology, 1991
- Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemiaBlood, 1991
- Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemiaBlood, 1989
- Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-upBlood, 1988
- High-Resolution Chromosomes as an Independent Prognostic Indicator in Adult Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1984